Starts human trial of zika vaccine Sinergium Biotech has been investigating a safe immunization against zika virus. It is expected that this year will begin tests in humans, after obtaining good results in mice in the preclinical stage. The zika virus expands throughout the region, and in the summer the countries seek to limit the circulation of the disease, transmitted by the same mosquito as dengue.
Protect Yourself & Others Protect yourself and others from Zika. Following these tips will help to protect you, your partner, your family, your friends, and your community from Zika. The more steps you take, the more protected you are.
If you are caring for a family member or friend with Zika, take steps to protect yourself from exposure to the person’s blood and body fluids.
Zika virus Overview Zika virus disease is caused by the Zika virus, which is spread to people primarily through the bite of an infected mosquito (
Aedes aegypti and
Aedes albopictus). The illness is usually mild with symptoms lasting up to a week, and many people do not have symptoms or will have only mild symptoms.
Questions about Zika Zika virus disease is caused by the Zika virus, which is spread to people primarily through the bite of an infected mosquito (
Aedes aegypti and
Aedes albopictus). The illness is usually mild with symptoms lasting up to a week, and many people do not have symptoms or will have only mild symptoms. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly and other severe brain defects.
Response to Zika in Four Latin American Countries In a new report on Zika in four Central American countries – Honduras, El Salvador, Dominican Republic and Guatemala – the Health Communication Capacity Collaborative (HC3) offers recommendations for improving the social and behavior change communication (SBCC) response to the virus. HC3 visited the four countries in March and April 2016 to quickly take the pulse of the Zika situation and the local response.
Zika Brings Multiple Inequalities to Light While Zika really can affect anyone, we also know that women who are faced with multiple inequalities are likely to be affected disproportionately…. We know how to try to reduce risk of Zika [at] multiple levels—it’s wearing bug repellent, it’s using screens on your windows, using air conditioning.
Treatment of zika virus almost found Several scientists in the world have devoted their knowledge and efforts to obtain a medicine or vaccine that can be used in people infected with the zika virus, transmitted by the Aedes aegypti mosquito, which also transmits dengue and chikungunya. The search for a chemical formula triggered laboratory alarms since the World Health Organization (WHO) issued, in early December 2015, an epidemiological alert against zika virus due to its relationship with the increase of newborns with Microcephaly. Since then, many scientific studies have been undertaken worldwide.
Pregnant During the Zika Outbreak My pregnancy began in March 2016, just a month after the World Health Organization declared Zika an international public health emergency. Although I work in health care as a nurse, I have felt uncertain about the course of this epidemic.
What health communicators can learn from Ebola Since the World Health Organisation declared Zika a global public health emergency in February of this year, much attention has been brought to bear on applying lessons learned during the Ebola crisis of 2014-15.
New Year update about Zika virus The Zika virus (ZIKV) is a mosquito-borne virus originally discovered in the Zika Forest area in Uganda in 1947. It was not considered a relevant pathogen for humans until the outbreaks of fever illness that occurred in the Pacific area in 2007, and later in 2013-14. However, it was its arrival and dramatic spread in Brazil and other Latin American and Caribbean countries that alarmed public health authorities and the scientific community.
Vaccine against zika is successful in mice The successful results of the first tests of the vaccine can be tested this year in humans. A zika vaccine developed by researchers in Brazil and the United States was effective in tests with laboratory mice and could be tested this year in humans, Brazilian authorities said. The successful results of the first tests of the vaccine developed jointly by researchers from the University of Texas, the National Institute of Health of the United States and the Brazilian state center for health studies Institute Evandro Chagas, were highlighted Monday in a published article In the journal Nature Medicine.
Guillain-Barré Syndrome Zika and Guillain-Barré Syndrome: Guillain-Barré syndrome (GBS) is an uncommon sickness of the nervous system in which a person’s own immune system damages the nerve cells, causing muscle weakness, and sometimes, paralysis.
Pregnant Women How to protect yourself? Until we know more, CDC recommends special precautions for pregnant women. Do not travel to areas with Zika. If you must travel, talk to your doctor or other healthcare provider first and take steps to plan for travel.